Imiquimod | MEDICIS Pharmaceuticals | ||
5% Ceam; Topical |
Less Than $1000 mn
|
||
Less Than 5
|
Less Than 5
|
||
Less Than 5
|
None | ||
More Than 5
|
Less Than 5
|
||
Used to treat certain types of growths on the skin. | |||
Yes
|
Aldara | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 | Patent 13 | Patent 14 | Patent 15 | Patent 16 | Patent 17 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
******* | *** ********* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* | ******* |
******* | *** ********* | ******* | ******* | ******* | *** ********* | *** ********* | *** ********* | *** ********* | *** ********* | *** ********* | *** ********* | *** ********* | *** ********* | *** ********* | *** ********* | *** ********* | *** ********* |
Company | FTF Status / 180 days exclusivity | 30-Months stay | Current Litigation Status | Current Approval Status | Likelihood of launch |
---|---|---|---|---|---|
******* | *** \ *** | ***, **** | ******* | ******** | ******** ** ***** **** |
******* | ** \ ** | ***, **** | ******* | ******** | ******** ** *** **** |